RMX Industries Files a Certificate of Change
RMX Industries filed a Certificate of Change with the Nevada Secretary of State on July 22, 2026, to amend its business entity information.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
RMX Industries filed a Certificate of Change with the Nevada Secretary of State on July 22, 2026, to amend its business entity information.
Taylor Morrison Home Corp filed an updated certificate of incorporation in Delaware. The filing amends the company's listing to conform with regulations effective Feb 20, 2024, upd…
Profound Medical announced data from its CAPTAIN trial where the TULSA Procedure demonstrated statistically significant superior penile length preservation compared to robotic radi…
NewAmsterdam and Menarini received a positive CHMP opinion patent dosing options for obicetrapib, pending further regulatory review.
Fly-E Group Inc. filed its Annual Report on Form 10-K after receiving a delinquency notice, averting an immediate risk of delisting. The company is now in compliance with Nasdaq's …
The company resolved all cybersecurity and software review items, de-risking the regulatory path for its fingerprint drug test. The move positions INBS for U.S. market entry into a…
EnerSys will prioritize aerospace and defense applications for its South Carolina lithium battery manufacturing facility. The refocus to serve critical national security supply cha…
Stone Point Credit Income Fund amended and restated its loan and security agreement with JPMorgan Chase Bank as administrative agent and its lenders, effective July 17, 2026.
Greenland Mines Ltd. has executed a Rights Agreement with Continental Stock Transfer & Trust Co., dated as of July 22, 2026. Legal counsel highlighted as Exhibit 4.1 in an SEC 8-K …
Inhibikase Therapeutics announced the FDA granted Orphan Drug Designation for its pulmonary arterial hypertension treatment, IKT-001. This benefit includes potential tax credits an…
Incannex has started screening participants for its IHL-42X Phase 2 OSA trial. The company previously received FDA Fast Track designation for the drug.
Investment firm Bleichroeder Acquisition Corp. II amended its Business Combination Agreement with Pasqal to modify the terms of an equity incentive plan prior to the deal's closing…
Kala Bio, Inc. announced that the SEC has declared effective the proxy statement related to its upcoming annual meeting. This regulatory clearance is required to proceed with share…
The FDA selected the first manufacturer for its Technology-Enabled Meaningful Patient Outcomes Pilot focused on digital health devices.
Bluejay Diagnostics completed enrollment in its SYMON-II study testing Symphony IL-6 for sepsis mortality risk ahead of plan, potentially supporting future regulatory filings and c…
The company filed an exhibit for an amended and restated revolving credit facility indenture and security agreement. The market relevance is neutral as it confirms existing planned…
Getty Realty filed an 8-K updating its corporate profile to incorporate information regarding the use of non-GAAP financial measures like FFO and AFFO.
Macau's Land and Urban Construction Bureau approved Wynn Resorts' application to expand Wynn Palace with a new hotel tower and event center. The approval omits casino floor alterat…
BridgeBio Pharma announced FDA acceptance of a new drug application for encaleret targeting autosomal dominant hypocalcemia type 1, setting a target action date of May 8, 2027, and…
Consolidated Water received a Limited Notice to Proceed from the Honolulu Board of Water Supply, authorizing approximately $6 million for the procurement of long-lead equipment for…